Accelerated Pharma Testing Business For Sale

IRELAND. YE24 TURNOVER £94,000The company focuses on accelerating pharmaceutical stability testing through its proprietary Accelerated Predictive Stability (APS) technology. By combining lab equipment, predictive modelling, and software, the company can reduce testing timelines from approximately six months to circa two-to-four weeks, making drug development faster and more efficient. The shareholders are seeking external investment to support the next phase of growth. Works with over 40 clients, covering major global pharmaceutical hubs. International reach spanning 18 countries, including the UK, the US, China, India, and key European markets. Utilises an APS platform built on established ASAP methodologies used by 16 of the top 20 global pharmaceutical companies. Reduces stability testing timelines from approximately six months to just two-to-four weeks. Led by a highly experienced management team recognised as specialists in ASAP methodologies and predictive stability modelling. Strong scientific credibility, reinforced through industry conference participation and published research. Offers invited.